Streptomycete biocontrol strains for managing fusarium TR4 in banana cultivation

Overview

Banana production worldwide faces a critical threat from Fusarium oxysporum f.sp. cubense, particularly the highly virulent Tropical Race 4 (TR4), which causes Panama disease and has no effective chemical control. This research proposes the use of streptomycetes, filamentous soil bacteria known for producing diverse biologically active secondary metabolites, as biocontrol agents against TR4 and R1 races. Approximately 400 streptomycete strains were isolated from five banana plantation soil samples and screened through dual culture assays against seven Fusarium strains. Forty strains showed activity against both R1 and TR4, with one strain achieving over 60% growth inhibition against both races. The proposed solution targets agricultural input companies, banana growers, and crop protection developers seeking sustainable disease management alternatives.

Technical specifications

Key features:

• A curated library of streptomycete strains with proven antagonistic activity against Fusarium oxysporum f.sp. cubense R1 and TR4
• One lead strain demonstrating greater than 60% in vitro growth inhibition against both pathogen races
• Strains naturally adapted to banana plantation soils, supporting establishment in target environments
• Endophytic capability enabling root colonization in addition to soil persistence
• Antifungal activity independent of volatile organic compound (VOC) production, suggesting stable metabolite-based mechanisms
• Strains characterized by morphotype grouping and geographic origin across multiple plantation sites

How it works:

The selected streptomycete strains produce secondary metabolites that directly inhibit the growth of Fusarium pathogens. Because these bacteria naturally inhabit banana soils and can colonize plant roots as endophytes, they can be applied through soil amendment or root bacterization to establish protective populations around banana plants before or during pathogen exposure.

Technology readiness level

The technology is currently at early-to-mid stage development. Laboratory validation is complete, with strain isolation, morphotype characterization, and dual culture screening finished. The lead strain has been identified through reproducible in vitro assays with adequate replication. Remaining work includes optimizing inoculum production through liquid and solid fermentation, developing plant bacterization protocols for transplantation, confirming inoculum persistence in soil and root colonization under greenhouse or field conditions, and validating disease suppression through controlled pathogen inoculation and trials in naturally infected soils. Future studies will also apply genomics and metabolomics to elucidate the specific biocontrol mechanisms. The technology is not yet ready for commercial deployment and requires additional greenhouse and field validation before regulatory or market entry.